HMB and vitamin D to protect muscle during semaglutide
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests whether taking HMB (a supplement) and vitamin D helps older adults keep their muscle while using semaglutide for weight loss. If you are starting semaglutide, this might help prevent muscle loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 65 and 85 years old.
- You have type 2 diabetes (HbA1c at least 6.5% or you take diabetes medication).
- Your body mass index (BMI) is 27 or higher.
- You are just starting semaglutide (like Ozempic or Wegovy) as part of your normal care.
- You can walk 400 meters (about 4 city blocks) with or without a cane.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.
This trial tests whether adding resistance exercise and extra protein can help you keep your muscle while taking weight loss medications like semaglutide or tirzepatide. It is for people with a BMI of 27 or higher who are not already exercising regularly.
This trial studies how brown fat (a type of body fat) changes after starting semaglutide for weight loss. You may help researchers understand how this medication affects the body’s energy use, which could improve weight-loss treatments.
This trial tests a new medicine, (S)-pindolol benzoate, given along with semaglutide (Ozempic/Wegovy). The goal is to see if it helps people lose mostly fat instead of muscle while on a weight loss program.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.